Stay updated on CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.

Latest updates to the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.6.5 appears, replacing Revision: v3.6.4. This indicates a newer build of the page without changes to the study information.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision tag updated to v3.6.4 on the page, reflecting a deployment-level change from the previous revision.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating an update to the page's revision label.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page shows a new revision label (v3.6.2) replacing the previous v3.6.0, indicating a minor update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check70 days agoChange DetectedNew sections provide guidance on reading the study record and joining the study. The recruitment status now indicates that no participants are being sought, and the Intervention/Treatment heading formatting has been adjusted.SummaryDifference0.5%

- Check77 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the record's metadata. No changes to the study data or eligibility criteria are implied.SummaryDifference0.1%

Stay in the know with updates to CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.